BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Bongkun Choi, Eun-Ju Chang. Biomarkers in Bone DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7745-3_40-1
2
CHIA-JUNG HSIEH, PO-LIN KUO, MING-FENG HOU, JEN-YU HUNG, FANG-RONG CHANG, YING-CHAN HSU, YA-FANG HUANG, EING-MEI TSAI, YA-LING HSU. Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signalingInternational Journal of Oncology 2015; 46(2): 555 doi: 10.3892/ijo.2014.2769
3
Bongkun Choi, Eun-Ju Chang. Biomarkers in Bone DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 253 doi: 10.1007/978-94-007-7693-7_40
4
Purushoth Ethiraj, Yuvaraj Sambandam, Jessica D. Hathaway‐Schrader, Azizul Haque, Chad M. Novince, Sakamuri V. Reddy. RANKL triggers resistance to TRAIL‐induced cell death in oral squamous cell carcinomaJournal of Cellular Physiology 2020; 235(2): 1663 doi: 10.1002/jcp.29086
5
Andy C-M Chang, Judy Doherty, Lily I. Huschtscha, Richard Redvers, Christina Restall, Roger R. Reddel, Robin L. Anderson. STC1 expression is associated with tumor growth and metastasis in breast cancerClinical & Experimental Metastasis 2015; 32(1): 15 doi: 10.1007/s10585-014-9687-9
6
Zhengxiao Ouyang, Xiaoning Guo, Xia Chen, Bo Liu, Qiang Zhang, Ziqing Yin, Zanjing Zhai, Xinhua Qu, Xuqiang Liu, Dan Peng, Yi Shen, Tang Liu, Qing Zhang. Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathwayOncotarget 2018; 9(2): 1868 doi: 10.18632/oncotarget.22930
7
Raúl M. Luque, Laura M. López-Sánchez, Alicia Villa-Osaba, Isabel M. Luque, Ana L. Santos-Romero, Elena M. Yubero-Serrano, María Cara-García, Marina Álvarez-Benito, José López-Miranda, Manuel D. Gahete, Justo P. Castaño. Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patientsOncotarget 2017; 8(46): 81462 doi: 10.18632/oncotarget.20399
8
Toshiyuki Yoneda, Masahiro Hiasa, Yuki Nagata, Tatsuo Okui, Fletcher A White. Acidic microenvironment and bone pain in cancer-colonized boneBoneKEy Reports 2015; 4 doi: 10.1038/bonekey.2015.58
9
Toshiyuki Yoneda, Masahiro Hiasa, Yuki Nagata, Tatsuo Okui, Fletcher White. Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone painBiochimica et Biophysica Acta (BBA) - Biomembranes 2015; 1848(10): 2677 doi: 10.1016/j.bbamem.2015.02.004
10
Ludwig Kiesel, Annemarie Kohl. Role of the RANK/RANKL pathway in breast cancerMaturitas 2016; 86: 10 doi: 10.1016/j.maturitas.2016.01.001
11
Yuvaraj Sambandam, Purushoth Ethiraj, Jessica D. Hathaway-Schrader, Chad M. Novince, Ezhil Panneerselvam, Kumaran Sundaram, Sakamuri V. Reddy. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cellsJournal of Cellular Physiology 2018; 233(8): 6125 doi: 10.1002/jcp.26456
12
Xiaoqiu Wu, Fangfei Li, Lei Dang, Chao Liang, Aiping Lu, Ge Zhang. RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic StrategiesFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00076
13
Hiroki Wakabayashi, Satoshi Wakisaka, Toru Hiraga, Kenji Hata, Riko Nishimura, Makoto Tominaga, Toshiyuki Yoneda. Decreased sensory nerve excitation and bone pain associated with mouse Lewis lung cancer in TRPV1-deficient miceJournal of Bone and Mineral Metabolism 2018; 36(3): 274 doi: 10.1007/s00774-017-0842-7
14
Subrata K Pore, Eun-Ryeong Hahm, Joseph D Latoche, Carolyn J Anderson, Yongli Shuai, Shivendra V Singh. Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanateCarcinogenesis 2018; 39(2): 134 doi: 10.1093/carcin/bgx114
15
Riko Kitazawa, Ryuma Haraguchi, Mana Fukushima, Sohei Kitazawa. Pathologic conditions of hard tissue: role of osteoclasts in osteolytic lesionHistochemistry and Cell Biology 2018; 149(4): 405 doi: 10.1007/s00418-018-1639-z
16
IJsbrand M. Kramer. Signal Transduction2016; : 477 doi: 10.1016/B978-0-12-394803-8.00008-5
17
R. Ajina, D. AlDeghaither, S. Jablonski, L.M. Weiner. Comprehensive Medicinal Chemistry III2017; : 32 doi: 10.1016/B978-0-12-409547-2.12426-6
18
Michael AB Naafs. Parathyroid Hormone Related Peptide (PTHrP): A Mini-ReviewEndocrinology&Metabolism International Journal 2017; 5(6) doi: 10.15406/emij.2017.05.00139
19
Bongkun Choi, Eun-Jin Lee, Da-Hyun Song, Sung-Chul Yoon, Yeon-Ho Chung, Youngsaeng Jang, Sang-Min Kim, Youngsup Song, Sang-Wook Kang, Seung-Yong Yoon, Eun-Ju Chang. Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic functionOncotarget 2014; 5(2): 481 doi: 10.18632/oncotarget.1664
20
Toru Hiraga. Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone MetastasesExpert Opinion on Investigational Drugs 2016; 25(3): 319 doi: 10.1517/13543784.2016.1142972
21
Suruchi Mittal, Nicola J. Brown, Ingunn Holen. The breast tumor microenvironment: role in cancer development, progression and response to therapyExpert Review of Molecular Diagnostics 2018; 18(3): 227 doi: 10.1080/14737159.2018.1439382
22
Ya-Ling Hsu, Eing-Mei Tsai, Ming-Feng Hou, Tsu-Nai Wang, Jen-Yu Hung, Po-Lin Kuo. Obtusifolin Suppresses Phthalate Esters-Induced Breast Cancer Bone Metastasis by Targeting Parathyroid Hormone-Related ProteinJournal of Agricultural and Food Chemistry 2014; 62(49): 11933 doi: 10.1021/jf5042905
23
Yuvaraj Sambandam, Sashank Sakamuri, Sundaravadivel Balasubramanian, Azizul Haque. RANK Ligand Modulation of Autophagy in Oral Squamous Cell Carcinoma Tumor CellsJournal of Cellular Biochemistry 2016; 117(1): 118 doi: 10.1002/jcb.25255
24
Hongwei Zhang. Bone Microenvironment and Role of Rank-Rankl-Opg in Breast Cancer Metastasis in BoneJournal of Cancer Prevention & Current Research 2017; 7(3) doi: 10.15406/jcpcr.2017.07.00234